Evidence map›Paper›PMID 37072865›Full record

ArticleParasites & vectors2023

Insecticide resistance status of Aedes aegypti in southern and northern Ghana.

Anisa Abdulai, Christopher Mfum Owusu-Asenso, Gabriel Akosah-Brempong, Abdul Rahim Mohammed, Isaac Kwame Sraku, Simon Kwaku Attah, Akua Obeng Forson, David Weetman, Yaw Asare Afrane

Abstract read
In one paragraph

Article in Parasites & vectors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The role of car tyres in the ecology ofCurrent research in parasitology & vector-borne diseases · 2024
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anisa AbdulaiDepartment of Medical Microbiology, Centre for Vector-Borne Disease Research, University of Ghana Medical School, University of Ghana, Accra, Ghana.
Christopher Mfum Owusu-AsensoDepartment of Medical Microbiology, Centre for Vector-Borne Disease Research, University of Ghana Medical School, University of Ghana, Accra, Ghana.
Gabriel Akosah-BrempongAfrican Regional Postgraduate Program in Insect Science, University of Ghana, Legon, Accra, Ghana.
Abdul Rahim MohammedDepartment of Medical Microbiology, Centre for Vector-Borne Disease Research, University of Ghana Medical School, University of Ghana, Accra, Ghana.
Isaac Kwame SrakuDepartment of Medical Microbiology, Centre for Vector-Borne Disease Research, University of Ghana Medical School, University of Ghana, Accra, Ghana.
Simon Kwaku AttahDepartment of Medical Microbiology, Centre for Vector-Borne Disease Research, University of Ghana Medical School, University of Ghana, Accra, Ghana.
Akua Obeng ForsonDepartment of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, University of Ghana, Accra, Ghana.
David WeetmanDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Yaw Asare AfraneDepartment of Medical Microbiology, Centre for Vector-Borne Disease Research, University of Ghana Medical School, University of Ghana, Accra, Ghana. yafrane@ug.edu.gh.

Funding

Regional Centre for Vector Borne Diseases in West Africa (RCVBD)D43TW011513 · FIC · UNIVERSITY OF GHANA · PI YAW ASARE AFRANE, Guiyun Yan · 2021 to 2026
$1.5M
FIC NIH HHS D43 TW011513
6 · The paper itself

Abstract

backgroundOutbreaks of Aedes-borne arboviral diseases are becoming rampant in Africa. In Ghana, there is no organized arboviral control programme with interventions restricted to mitigate outbreaks. Insecticide application is a crucial part of outbreak responses and future preventative control measures. Thus, knowledge of the resistance status and underlying mechanisms of Aedes populations is required to ensure optimal insecticide choices. The present study assessed the insecticide resistance status of Aedes aegypti populations from southern Ghana (Accra, Tema and Ada Foah) and northern Ghana (Navrongo) respectively.

methodsPhenotypic resistance was determined with WHO susceptibility tests using Ae. aegypti collected as larvae and reared into adults. Knockdown resistance (kdr) mutations were detected using allele-specific PCR. Synergist assays were performed with piperonyl butoxide (PBO) to investigate the possible involvement of metabolic mechanisms in resistance phenotypes.

resultsResistance to DDT was moderate to high across sites (11.3 to 75.8%) and, for the pyrethroids deltamethrin and permethrin, moderate resistance was detected (62.5 to 88.8%). The 1534C kdr and 1016I kdr alleles were common in all sites (0.65 to 1) and may be on a trajectory toward fixation. In addition, a third kdr mutant, V410L, was detected at lower frequencies (0.03 to 0.31). Pre-exposure to PBO significantly increased the susceptibility of Ae. aegypti to deltamethrin and permethrin (P < 0.001). This indicates that in addition to kdr mutants, metabolic enzymes (monooxygenases) may be involved in the resistance phenotypes observed in the Ae. aegypti populations in these sites.

conclusionInsecticide resistance underpinned by multiple mechanisms in Ae. aegypti indicates the need for surveillance to assist in developing appropriate vector control strategies for arboviral disease control in Ghana.

Indexed as

AedesInsecticidesPyrethrinsAnimalsGhanaInsecticide ResistanceMosquito VectorsMutationNitrilesPermethrindecamethrinInsecticidesNitrilesPermethrinPyrethrinsAedes aegyptiGhanaInsecticide resistanceKnockdown resistancePiperonyl butoxide synergistTarget-site mutations

Identifiers

PMID37072865
PMCPMC10111668

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.